Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Wyeth and Takeda Pharmaceutical Company have launched Enbrel 25mg Syringe 0.5mL for SC Injection, a new formulation of Enbrel for the treatment of rheumatoid arthritis, that is being co-promoted by the two companies.
Subscribe to our email newsletter
Enbrel 25mg Syringe 0.5mL for SC Injection is a new formulation of the existing Enbrel 25mg for SC Injection, with the drug pre-filled into the syringe.
According to the company, the launch of Enbrel 25mg Syringe 0.5mL for SC Injection offers easier preparations for administration for patients who self-inject Enbrel as well as medical professionals, leading to a decrease in the burden for them.